COMPARISON BETWEEN ALPHA-ADRENERGICMEDIATED AND K-OPIOIDERGIC-MEDIATED INOSITOL(1,4,5)P3 INOSITOL(1,3,4,5)P4 FORMATION IN ADULT CULTURED RAT VENTRICULAR CARDIOMYOCYTES

被引:40
|
作者
VENTURA, C
GUARNIERI, C
STEFANELLI, C
CIRIELLI, C
LAKATTA, EG
CAPOGROSSI, MC
机构
[1] UNIV BOLOGNA,DEPT BIOCHEM,I-40126 BOLOGNA,ITALY
[2] NIA,GERONTOL RES CTR,CARDIOVASC SCI LAB,BALTIMORE,MD 21224
关键词
D O I
10.1016/0006-291X(91)91913-W
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In adult cultured rat ventricular cardiac myocytes, both the α-adrenergic agonist phenylephrine and the selective K opioid receptor ligand U-50,488H affected phosphoinositide turnover. Phenylephrine, over a time course of 10 min, caused a transient increase in Ins(1,4,5)P3 which peaked at 1 min and had returned to control at 2 min. In addition, phenylephrine produced a progressive and sustained increase in the formation of Ins(1,3,4, 5)P4 which achieved a plateau after 5 min of exposure to the agonist. U-50,488H induced an increase in Ins(1,4,5)P3 which peaked at 1 min at a level significantly higher than that due to phenylephrine and was still elevated after 10 min exposure to the K opioid receptor agonist. In addition, U-50,488H caused a sustained increase in Ins(1,3,4,5)P4 which was comparable to that due to phenylephrine. The stimulatory effects produced by phenylephrine and U-50,488H were receptor-mediated events, since they were fully antagonized by their respective antagonists, phentolamine or Mr-1452. © 1991.
引用
收藏
页码:972 / 978
页数:7
相关论文
共 50 条
  • [21] COMPARISON OF INOSITOL 1,4,5-TRISPHOSPHATE AND INOSITOL 1,3,4,5-TETRAKISPHOSPHATE BINDING-SITES IN CEREBELLUM
    CHALLISS, RAJ
    WILLCOCKS, AL
    POTTER, BVL
    NAHORSKI, SR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : S151 - S151
  • [22] Autoradiographic characterization of [H-3]inositol(1,4,5)trisphosphate and [H-3]inositol(1,3,4,5)tetrakisphosphate binding sites in human brain
    Kurumatani, T
    Cowburn, RF
    Bogdanovic, N
    Winblad, B
    Fastbom, J
    JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (2-3) : 175 - 189
  • [23] Autoradiographic characterization of [3H]inositol (1,4,5) trisphosphate and [3H]inositol (1,3,4,5) tetrakisphosphate binding sites in human brain
    T. Kurumatani
    R. F. Cowburn
    N. Bogdanovic
    B. Winblad
    J. Fastbom
    Journal of Neural Transmission, 1997, 104 : 175 - 189
  • [24] Dimers of D-myo-inositol 1,4,5-trisphosphate:: Design, synthesis, and interaction with Ins(1,4,5)P3 receptors
    Riley, AM
    Laude, AJ
    Taylor, CW
    Potter, BVL
    BIOCONJUGATE CHEMISTRY, 2004, 15 (02) : 278 - 289
  • [25] Ins(1,4,5)P3 regulates phospholipase Cβ1 expression in cardiomyocytes
    Vasilevski, Oliver
    Grubb, David R.
    Filtz, Theresa M.
    Yang, Sundy
    McLeod-Dryden, Tiffany J.
    Luo, Jieting
    Karna, Divya
    Chen, Ju
    Woodcock, Elizabeth A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 (05) : 679 - 684
  • [26] Relative importance of inositol (1,4,5)trisphosphate and inositol (1,3,4, 5)tetrakisphosphate in Entamoeba histolytica
    Giri, B
    Raha, S
    Bhattacharyya, B
    Biswas, S
    Biswas, BB
    FEBS LETTERS, 1996, 393 (01) : 109 - 112
  • [27] Synthesis of potent Ins(1,4,5)P3 5-phosphatase inhibitors by modification of myo-inositol 1,3,4,6-tetrakisphosphate
    Mills, SJ
    Potter, BVL
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (19) : 4245 - 4253
  • [28] CHARACTERIZATION OF INOSITOL 1,4,5-TRISPHOSPHATE-BINDING AND INOSITOL 1,3,4,5-TETRAKISPHOSPHATE-BINDING SITES IN RAT CEREBELLUM
    CHALLISS, RAJ
    WILLCOCKS, AL
    MULLOY, B
    POTTER, BVL
    NAHORSKI, SR
    BIOCHEMICAL JOURNAL, 1991, 274 : 861 - 867
  • [29] Ins(1,4,5)P3 and cardiac dysfunction
    Woodcock, EA
    Matkovich, SJ
    Binah, O
    CARDIOVASCULAR RESEARCH, 1998, 40 (02) : 251 - 256
  • [30] Ins(1,4,5)P3:: a messenger for hearing
    Bruzzone, R
    Cohen-Salmon, M
    M S-MEDECINE SCIENCES, 2005, 21 (6-7): : 585 - 588